Clinical Trial Update: Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemoradiotherapy plus immunotherapy followed by surgery for esophageal cancer in a neoadjuvant setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Esophagus Cancer, Neoadjuvant Therapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING